Switching from Semaglutide to Tirzepatide: When Physicians Consider It
How a weight loss plateau or persistent side effects can prompt a physician-supervised change from semaglutide to tirzepatide.
Physicians most often consider switching from semaglutide to tirzepatide when weight loss has plateaued despite a full therapeutic dose, or when side effects make semaglutide difficult to tolerate. The change is never automatic. In a supervised switch, a physician reviews your history, selects a conservative tirzepatide starting dose, and follows up closely during the first weeks to confirm the new medication is working and well tolerated.
When physicians consider a switch
Many patients respond well to semaglutide, and a slowdown in weight loss does not automatically mean the medication has failed. Physicians look at the full picture before recommending a change, and at New Hope Weight Loss, Dr. Anjmun Sharma, MD evaluates each case individually rather than applying a one-size-fits-all rule. The situations that most often prompt the conversation include:
- A true plateau: weight has held steady for several weeks at the highest dose a patient tolerates, with nutrition and habits still on track.
- Tolerability problems: persistent nausea, reflux, or other digestive side effects that do not settle with dose adjustments.
- Distance to goal: a patient with significant weight still to lose may be a candidate for a medication with a different mechanism.
How semaglutide and tirzepatide differ
Semaglutide works on the GLP-1 receptor, which influences appetite, fullness, and blood sugar. Tirzepatide acts on two receptors, GIP and GLP-1, so it works through a related but distinct pathway. The brand versions of these drugs, Wegovy and Ozempic for semaglutide and Zepbound and Mounjaro for tirzepatide, are FDA-approved medications.
Ready to start?
$199 Skeptics’ Trial, see if it works for you
One month of medical-grade compounded semaglutide, the $119 doctor review, and a free B-12/lipotropic injection. No long-term commitment.
Start the 30-day trialNew Hope Weight Loss prescribes compounded semaglutide and compounded tirzepatide, which are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA. That distinction is explained in every consultation, so patients understand exactly what they are taking before any switch is considered.
How a supervised switch works
A switch starts with a $119 medical review. Dr. Sharma looks at your response to semaglutide, your side effect history, current medications, and overall health. If tirzepatide is the better fit, she sets a plan: semaglutide is stopped on schedule, and tirzepatide begins at a conservative starting dose. There is no milligram-to-milligram conversion between the two medications, which is one reason changing on your own is unsafe.
From there, the dose is adjusted gradually based on your results and how you feel. Follow-ups happen in person at the Costa Mesa clinic or by telehealth, so adjustments never require a long wait.
What to expect after switching
Mild digestive side effects can reappear during the first weeks on tirzepatide, even if your body had adjusted to semaglutide, because the dose is titrated up again. Patients are asked to judge progress over several weeks rather than days. Cost also changes: compounded semaglutide starts at $166 per month, while compounded tirzepatide starts at $233 per month, and that difference is discussed before any decision is final. Whatever the plan, medication changes are always made by the physician, never on your own.
What you can start today at New Hope Weight Loss
After a one-time $119 medical review with Dr. Sharma, eligible patients begin physician-supervised compounded semaglutide from $166 a month or compounded tirzepatide from $233 a month, with a $199 one-month Skeptics' Trial. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality. In person in Orange County and by telehealth across California and additional states.
Frequently asked questions
Can I switch from semaglutide to tirzepatide on my own?
No. The two medications dose differently, and there is no direct conversion between them. Any switch should be planned and monitored by a physician such as Dr. Anjmun Sharma, MD.
Why would a physician switch me from semaglutide to tirzepatide?
The most common reasons are a weight loss plateau at a full tolerated dose, or side effects that do not improve with dose adjustments. The decision always follows a medical review of your individual case.
Is a plateau on semaglutide normal?
Yes, weight loss often slows after the first months as the body adapts. A plateau does not automatically mean you need a different medication; sometimes a dose or habit adjustment is enough.
How much does it cost to switch to tirzepatide at New Hope Weight Loss?
The medical review is $119, compounded tirzepatide starts at $233 per month, and compounded semaglutide starts at $166 per month. New patients can also begin with the $199 one-month Skeptics' Trial, which includes a free B-12/lipotropic injection.
Is compounded tirzepatide the same as Zepbound or Mounjaro?
No. Zepbound and Mounjaro are FDA-approved brand medications, while compounded tirzepatide is prepared by licensed U.S. pharmacies and is not FDA-approved, not brand-identical, and not reviewed by the FDA.
This article is informational only and not medical advice. Speak with a licensed physician before starting or changing any GLP-1 therapy. Individual results vary. New Hope Weight Loss is a physician-supervised medical weight loss clinic in Costa Mesa, CA. Eligibility for treatment is determined during the medical consultation. Compounded semaglutide and compounded tirzepatide are not the same products as Wegovy®, Ozempic®, Mounjaro®, or Zepbound®.